Old Web
English
Sign In
Acemap
>
Paper
>
PBI39 CHARACTERISTICS OF PATIENTS INITIATING GUSELKUMAB FOR PLAQUE PSORIASIS DURING THE FRIST YEAR FOLLOWING US APPROVAL
PBI39 CHARACTERISTICS OF PATIENTS INITIATING GUSELKUMAB FOR PLAQUE PSORIASIS DURING THE FRIST YEAR FOLLOWING US APPROVAL
2019
A. Teeple
T Fitzgerald
T. Slaton
C.M. Kozma
Keywords:
Intensive care medicine
Guselkumab
Psoriasis
Medicine
plaque psoriasis
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]